查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1831884

2025 年至 2033 年乾癬性關節炎治療市場報告（按藥物類型（非類固醇抗發炎藥、緩解風濕性關節炎藥物、生物製劑及其他）、類型、給藥途徑、配銷通路和地區分類）

Psoriatic Arthritis Treatment Market Report by Drug Type (NSAIDs, DMARDs, Biologics, and Others), Type, Route of Administration, Distribution Channel, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

2024年全球乾癬性關節炎治療市場規模達105億美元。展望未來， IMARC Group預計到2033年市場規模將達到232億美元，2025-2033年期間的成長率（CAGR）為8.71%。

銀屑病關節炎是一種自體免疫疾病，免疫系統攻擊關節並引起發炎。其治療方法多種多樣，從減輕腫脹和發炎的口服藥物到針對特定免疫系統的生物療法。治療方案根據疼痛、腫脹和僵硬程度而定。目前，主要參與者正在推出新的治療方法，以幫助預防疾病進展、減輕疼痛、保護關節並保持關節活動範圍。這些方法可以與物理治療相結合，以增強肌肉和關節功能，並提高整體穩定性。

銀屑病關節炎治療市場趨勢：

銀屑病是乾癬性關節炎的主要危險因子之一。因此，由於感染、壓力、肥胖、皮膚損傷、酗酒和維生素缺乏導致銀屑病患病率不斷上升，是影響市場的主要因素之一。此外，由於乾癬性關節炎最常發生在 30 至 50 歲之間的人群中，全球成年人口的成長也促進了市場的成長。除此之外，患有乾癬性關節炎的兒童更容易患上影響眼壁中層組織的葡萄膜炎。這一點，加上父母對孩子健康的日益關注，正在催化全球對乾癬性關節炎治療的需求。此外，人們越來越意識到早期診斷和治療乾癬性關節炎的好處，例如可以預防嚴重損害，這也促進了市場的成長。其他因素，例如個人可支配收入的增加、醫療設施的改善以及個人健康意識的增強，預計將推動對新型乾癬性關節炎治療的需求，以對抗嚴重症狀。

本報告回答的關鍵問題：

  • 全球乾癬性關節炎治療市場迄今表現如何，未來幾年將如何表現？
  • COVID-19 對全球乾癬性關節炎治療市場有何影響？
  • 主要的區域市場有哪些？
  • 根據藥物類型，市場是如何分類的？
  • 根據類型，市場區隔是怎樣的？
  • 根據行政路徑，市場如何分類？
  • 根據配銷通路，市場是如何分類的？
  • 該產業的價值鏈分為哪些階段？
  • 該行業的主要促進因素和挑戰是什麼？
  • 全球乾癬性關節炎治療市場的結構是怎麼樣的？主要參與者是誰？
  • 產業競爭程度如何？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球銀屑病關節炎治療市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依藥物類型

  • 非類固醇抗發炎藥（NSAIDs）
  • DMARDs（改善病情的抗風濕藥物）
  • 生物製劑
  • 其他

第7章：市場區隔：依類型

  • 處方
  • 場外交易

第8章：市場區隔：依行政途徑

  • 注射劑
  • 口服
  • 外用

第9章：市場區隔：按配銷通路

  • 醫院藥房
  • 零售藥局
  • 網路藥局

第10章：市場細分：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 11 章：SWOT 分析

第 12 章：價值鏈分析

第 13 章：波特五力分析

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • AbbVie Inc.
    • Amgen Inc.
    • Amneal Pharmaceuticals LLC
    • AstraZeneca plc
    • Bristol-Myers Squibb Company
    • Eisai Co. Ltd.
    • Eli Lilly and Company
    • Johnson & Johnson Service ltd.
    • Novartis AG
    • Pfizer Inc.
    • Samsung Biologics
    • UCB SA
Product Code: SR112025A4541

The global psoriatic arthritis treatment market size reached USD 10.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 23.2 Billion by 2033, exhibiting a growth rate (CAGR) of 8.71% during 2025-2033.

Psoriatic arthritis is an autoimmune disorder wherein the immune system attacks the joints and causes inflammation. Its treatment options vary from oral medications that reduce swelling and inflammation to biological therapies that target the specific immune system. It is treated as per the level of pain, swelling, and stiffness. At present, key players are introducing new treatment methods that help prevent disease progression, reduce pain, protect joints, and preserve the range of motion. These methods can be combined with physical therapy to strengthen muscles and joints and increase overall stability.

Psoriatic Arthritis Treatment Market Trends:

Psoriasis disease is one of the major risk factors for psoriatic arthritis. As a result, the increasing prevalence of psoriasis disease due to infection, stress, obesity, skin injuries, alcohol abuse, and vitamin deficiencies represents one of the primary factors influencing the market positively. Moreover, as psoriatic arthritis occurs most commonly among individuals between the ages of 30 and 50, the rising adult population worldwide is contributing to the market growth. Apart from this, children with psoriatic arthritis are more likely to develop uveitis that affects the middle layer of tissue in the eyewall. This, in confluence with the growing concerns among parents about the health of their children, is catalyzing the demand for psoriatic arthritis treatment across the globe. In addition, the rising awareness about the benefits of early diagnosis and treatment of psoriatic arthritis, such as preventing serious damages, is bolstering the market growth. Other factors, such as inflating disposable income of individuals, improvement in healthcare facilities, and the growing health awareness among individuals, are anticipated to drive the demand for novel psoriatic arthritis treatment to combat severe symptoms.

Key Market Segmentation:

Breakup by Drug Type:

  • NSAIDs (Nonsteroidal Anti-Inflammatory drugs)
  • DMARDs (Disease-Modifying Anti-Rheumatic Drugs)
  • Biologics
  • Others

Breakup by Type:

  • Prescription
  • OTC

Breakup by Route of Administration:

  • Injectable
  • Oral
  • Topical

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., Amneal Pharmaceuticals LLC, AstraZeneca plc, Bristol-Myers Squibb Company, Eisai Co. Ltd., Eli Lilly and Company, Johnson & Johnson Service ltd., Novartis AG, Pfizer Inc., Samsung Biologics and UCB S.A.

Key Questions Answered in This Report:

  • How has the global psoriatic arthritis treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global psoriatic arthritis treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global psoriatic arthritis treatment market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Psoriatic Arthritis Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Type

  • 6.1 NSAIDs (Nonsteroidal Anti-Inflammatory Drugs)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 DMARDs (Disease-Modifying Anti-Rheumatic Drugs)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Biologics
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Type

  • 7.1 Prescription
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 OTC
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Injectable
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oral
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Topical
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospital Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AbbVie Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Amgen Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Amneal Pharmaceuticals LLC
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 AstraZeneca plc
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Bristol-Myers Squibb Company
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Eisai Co. Ltd.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Eli Lilly and Company
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Johnson & Johnson Service ltd.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Novartis AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Samsung Biologics
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
    • 15.3.12 UCB S.A.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Psoriatic Arthritis Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Psoriatic Arthritis Treatment Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Psoriatic Arthritis Treatment Market: Breakup by Drug Type (in %), 2024
  • Figure 5: Global: Psoriatic Arthritis Treatment Market: Breakup by Type (in %), 2024
  • Figure 6: Global: Psoriatic Arthritis Treatment Market: Breakup by Route of Administration (in %), 2024
  • Figure 7: Global: Psoriatic Arthritis Treatment Market: Breakup by Distribution Channel (in %), 2024
  • Figure 8: Global: Psoriatic Arthritis Treatment Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Psoriatic Arthritis Treatment (NSAIDs-Nonsteroidal Anti-Inflammatory Drugs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Psoriatic Arthritis Treatment (NSAIDs-Nonsteroidal Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Psoriatic Arthritis Treatment (DMARDs-Disease-Modifying Anti-Rheumatic Drugs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Psoriatic Arthritis Treatment (DMARDs-Disease-Modifying Anti-Rheumatic Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Psoriatic Arthritis Treatment (Biologics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Psoriatic Arthritis Treatment (Biologics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Psoriatic Arthritis Treatment (Other Drug Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Psoriatic Arthritis Treatment (Other Drug Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Psoriatic Arthritis Treatment (Prescription) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Psoriatic Arthritis Treatment (Prescription) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Psoriatic Arthritis Treatment (OTC) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Psoriatic Arthritis Treatment (OTC) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Psoriatic Arthritis Treatment (Injectable) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Psoriatic Arthritis Treatment (Injectable) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Psoriatic Arthritis Treatment (Oral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Psoriatic Arthritis Treatment (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Psoriatic Arthritis Treatment (Topical) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Psoriatic Arthritis Treatment (Topical) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Psoriatic Arthritis Treatment (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Psoriatic Arthritis Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Psoriatic Arthritis Treatment (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Psoriatic Arthritis Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Psoriatic Arthritis Treatment (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Psoriatic Arthritis Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: North America: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: North America: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: United States: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: United States: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Canada: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Canada: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Asia-Pacific: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Asia-Pacific: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: China: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: China: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Japan: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Japan: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: India: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: India: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: South Korea: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: South Korea: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Australia: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Australia: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Indonesia: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Indonesia: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Others: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Others: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Europe: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Europe: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Germany: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Germany: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: France: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: France: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: United Kingdom: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: United Kingdom: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Italy: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Italy: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Spain: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Spain: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Russia: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Russia: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Others: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Others: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Latin America: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Latin America: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Brazil: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Brazil: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Mexico: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Mexico: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Others: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Others: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Middle East and Africa: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Middle East and Africa: Psoriatic Arthritis Treatment Market: Breakup by Country (in %), 2024
  • Figure 81: Middle East and Africa: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Global: Psoriatic Arthritis Treatment Industry: SWOT Analysis
  • Figure 83: Global: Psoriatic Arthritis Treatment Industry: Value Chain Analysis
  • Figure 84: Global: Psoriatic Arthritis Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Psoriatic Arthritis Treatment Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
  • Table 3: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 4: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 5: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 6: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Psoriatic Arthritis Treatment Market: Competitive Structure
  • Table 8: Global: Psoriatic Arthritis Treatment Market: Key Players